J, K., JV, P., HP, M., L, K., D, M., EM, L., & PR, C. (2024). Downstream STING pathways IRF3 and NF-κB differentially regulate CCL22 in response to cytosolic dsDNA. Cancer gene therapy, 31(1), 28. https://doi.org/10.1038/s41417-023-00678-z
Chicago Style (17th ed.) CitationJ, Kim, Pena JV, McQueen HP, Kong L, Michael D, Lomashvili EM, and Cook PR. "Downstream STING Pathways IRF3 and NF-κB Differentially Regulate CCL22 in Response to Cytosolic DsDNA." Cancer Gene Therapy 31, no. 1 (2024): 28. https://doi.org/10.1038/s41417-023-00678-z.
MLA (9th ed.) CitationJ, Kim, et al. "Downstream STING Pathways IRF3 and NF-κB Differentially Regulate CCL22 in Response to Cytosolic DsDNA." Cancer Gene Therapy, vol. 31, no. 1, 2024, p. 28, https://doi.org/10.1038/s41417-023-00678-z.